Association Between the Remnant Cholesterol Inflammation Index and Cardiac Syndrome X
Diagnostics · 08.04.2026 · 16 (8) · 1113
DOI: 10.3390/diagnostics16081113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 08.04.2026. Verfasst von İbrahim Aktaş und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Faculty of Medicine, Malatya Turgut Özal University, 44090 Malatya, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Cardiac Syndrome X (CSX), a clinical entity within the Ischaemia with Non-Obstructive Coronary Arteries (INOCA) spectrum, is increasingly recognised as an inflammatory and systemic vascular disorder. Remnant cholesterol (RC) and inflammation are emerging contributors to residual cardiovascular risk; however, their combined role in microvascular angina remains unclear. This study aimed to evaluate the association between the remnant cholesterol inflammation index (RCII), integrating RC and high-sensitivity C-reactive protein (hs-CRP), and the clinical presence of CSX.
Methods
This single-centre, retrospective observational study included 392 individuals who underwent coronary angiography between January 2023 and January 2025. The study population comprised 197 patients diagnosed with CSX and 195 control subjects with normal coronary anatomy and no objective evidence of myocardial ischaemia. RC was calculated as total cholesterol minus the sum of LDL-C and HDL-C, and RCII was derived as RC × hs-CRP. Importantly, invasive microvascular testing (e.g., CFR or IMR) was not performed. Logistic regression analyses were performed to identify independent predictors of CSX, and receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic performance.
Results
Patients with CSX exhibited significantly higher levels of hs-CRP, SII, and RCII compared with controls (all p < 0.001). In the multivariable logistic regression analysis, RCII demonstrated an independent association with CSX (odds ratio 1.095, 95% confidence interval 1.060–1.131; p < 0.001). ROC curve analysis showed that RCII provided moderate but significant discrimination for CSX (area under the curve [AUC] 0.765, 95% CI 0.695–0.795). Pairwise comparisons confirmed that RCII had a significantly higher AUC than RC, hs-CRP, or SII individually.
Conclusions
Higher RCII levels appear to be significantly associated with the clinical diagnosis of CSX. By integrating atherogenic remnant cholesterol burden and systemic inflammation, RCII may serve as a valuable composite biomarker for identifying residual inflammatory lipid risk. Rather than acting as a definitive diagnostic tool, these findings warrant further validation in large-scale prospective cohort studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Faculty of Medicine, Malatya Turgut Özal University, 44090 Malatya, Türkiye.
- Department of Cardiology, Malatya Training and Research Hospital, 44090 Malatya, Türkiye.
ORCID-Profile: Erdoğan Yaşar
Zitieren
APA
Aktaş, İ., Yaşar, E., & Uçkaç, K. (2026). Association Between the Remnant Cholesterol Inflammation Index and Cardiac Syndrome X. Diagnostics, 16(8), 1113. https://doi.org/10.3390/diagnostics16081113
Vancouver
Aktaş İ, Yaşar E, Uçkaç K. Association Between the Remnant Cholesterol Inflammation Index and Cardiac Syndrome X. Diagnostics. 2026;16(8):1113. doi:10.3390/diagnostics16081113
BibTeX
@article{Akta2026,
author = {Aktaş, İbrahim and Yaşar, Erdoğan and Uçkaç, Kadir},
title = {Association Between the Remnant Cholesterol Inflammation Index and Cardiac Syndrome X},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {8},
pages = {1113},
doi = {10.3390/diagnostics16081113}
}
EUVIMED